Skip to main content

ADVERTISEMENT

Surabhi Dangi-Garimella, PhD

Viewpoint
08/19/2019
Surabhi Dangi-Garimella, PhD
The value conversation for a drug, especially from a patient’s perspective, extends well beyond merely drug cost. In addition to utilization of cost-effectiveness analyses, decision makers need access to all relevant...
The value conversation for a drug, especially from a patient’s perspective, extends well beyond merely drug cost. In addition to utilization of cost-effectiveness analyses, decision makers need access to all relevant...
The...
08/19/2019
Journal of Clinical Pathways